XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.
Learning Sparsity for Effective and Efficient Music Performance Question Answering
1 Pith paper cite this work. Polarity classification is still indexing.
abstract
Music performances, characterized by dense and continuous audio as well as seamless audio-visual integration, present unique challenges for multimodal scene understanding and reasoning. Recent Music Performance Audio-Visual Question Answering (Music AVQA) datasets have been proposed to reflect these challenges, highlighting the continued need for more effective integration of audio-visual representations in complex question answering. However, existing Music AVQA methods often rely on dense and unoptimized representations, leading to inefficiencies in the isolation of key information, the reduction of redundancy, and the prioritization of critical samples. To address these challenges, we introduce Sparsify, a sparse learning framework specifically designed for Music AVQA. It integrates three sparsification strategies into an end-to-end pipeline and achieves state-of-the-art performance on the Music AVQA datasets. In addition, it reduces training time by 28.32% compared to its fully trained dense counterpart while maintaining accuracy, demonstrating clear efficiency gains. To further improve data efficiency, we propose a key-subset selection algorithm that selects and uses approximately 25% of MUSIC-AVQA v2.0 training data and retains 70-80% of full-data performance across models.
citation-role summary
citation-polarity summary
fields
cs.LG 1years
2025 1verdicts
REJECT 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkers
XGBoost combining MRI radiomics and clinical biomarkers reportedly reaches C-index 0.782 for early brain tumor recurrence, but the paper's methods describe a liver-cancer cohort and no evaluation of its claimed temporal module appears.